AI assistant could help junior doctors plan lung cancer surgeries
NCT ID NCT07654036
First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 5 times
Summary
This study tests a new AI tool called GAPS-Agent that helps doctors plan surgeries for lung cancer. The tool is designed to assist less experienced doctors in making complex decisions. Researchers will compare AI-generated plans to those from a standard AI, and expert surgeons will judge which plans are better. The study is very small with only 12 participants and aims to gather initial data for larger future trials.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- GAPS-Agent (an AI tool that helps doctors plan lung cancer surgeries)
- What this could lead to
- If successful, this could show that AI can help less experienced doctors create better surgical plans for lung cancer, potentially improving patient care.
- What could go wrong
- This is a very small, early study with only 12 participants. It measures expert preference, not actual patient outcomes, so the real-world benefit is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
8 people
The number who actually took part.
- Started
-
Jun 2026
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Resident Physician Subjects: 1. Holds a valid and legally effective Physician Practice License of the People's Republic of China; 2. Currently holds the rank of resident physician in a thoracic surgery department at a tertiary Class A (3A) hospital; 3. Agrees to complete all assessment tasks of the main study phase in accordance with the study protocol; 4. Can guarantee the time and effort required to complete all assessment tasks of the main study. 2. Study Cases: 1. The case was discussed at the Thoracic Oncology Multidisciplinary Team (MDT) conference of Peking University People's Hospital between January 2025 and May 2026; 2. The current version of the NCCN guidelines does not provide an explicit recommendation covering the management of the case; 3. Does not overlap with the GAPS evaluation set; 4. The case is presented in pure text in a structured format, with all direct and indirect identifiers removed and complete de-identification performed prior to inclusion; 5. From the pool of eligible cases, 12 cases will be randomly drawn using Python (numpy.random, with a fixed and archived seed) to serve as the main study cases. The cases will cover 6 themes (chest mass of undetermined diagnosis, early-stage lung cancer, locally advanced lung cancer, oligometastatic/oligoprogressive disease, special intraoperative situations, and tumor recurrence), with 1 - 4 cases per theme. 3. Adjudication Expert Panel: 1. Holds a valid and legally effective Physician Practice License of the People's Republic of China; 2. Currently holds the rank of attending physician or above in a thoracic surgery department at a tertiary Class A hospital; 3. Chairs or regularly participates in lung cancer multidisciplinary team (MDT) work in their department. Exclusion Criteria: 1. Resident Physician Subjects: 1. Has previously participated in the construction of the GAPS evaluation set or the development of GAPS-Agent; 2. Unable to complete the tasks of the study phase. 2. Study Cases: 1. Key case information is missing, such as text-form data on pathology (including IHC/NGS), imaging, laboratory tests, prior medical history, comorbidities, or PS score; 2. Decision-making for the case is strictly dependent on non-text information. 3. Adjudication Expert Panel: 1. Participated in the construction of the GAPS evaluation set, the content validity verification, or the development of GAPS-Agent for this study; 2. Has a direct conflict of interest with any specific product among the two-arm tools of this study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Large language models are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University People's Hospital
Beijing, Beijing Municipality, 100044, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a structured exercise plan speed recovery after lung cancer surgery?
- Can a nutrition plan help lung cancer patients stay stronger?
- Can a targeted pill clear hidden lung cancer cells after surgery?
- Can a needle at the knee supercharge lung cancer immunotherapy?
- Can electric pulses destroy lung tumors without surgery?
- Can radiation spare the brain while fighting cancer in the spinal fluid?